S โ€” Community Improvement & Capacity BuildingEIN: 850837695ยท Ruling Year: 2022

Subcutaneous Drug Development & Delivery Consortium Inc

Beaverton, Oregon

B-Health Score
48B-

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Average

๐Ÿ’ฐ
$760K
Total Revenue
๐Ÿ“Š
$769K
Total Expenses
๐Ÿฆ
$626K
Net Assets
๐Ÿ“‹
$276K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+87.1%
Year-over-year change (2022 โ†’ 2023)
Net Margin
-1.2%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.81
Net assets divided by total expenses
Liabilities-to-Assets
30.6%
Total liabilities as % of total assets

Filing History

4 filings on record
YearRevenueExpensesAssets
2023$760,000โ†‘87%$769,199โ†‘43%$901,226โ†‘31%
2022$406,250โ†“32%$537,991โ†‘92%$685,644โ†“21%
2021$600,000โ†‘20%$280,411โ†‘428%$868,101โ†‘19%
2020$500,000$53,145$726,531

Frequently Asked Questions

What does Subcutaneous Drug Development & Delivery Consortium Inc do?โ–ผ

Subcutaneous Drug Development & Delivery Consortium Inc is a community improvement & capacity building nonprofit organization based in Oregon. It is classified under NTEE code S46 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Subcutaneous Drug Development & Delivery Consortium Inc financially healthy?โ–ผ

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Subcutaneous Drug Development & Delivery Consortium Inc.

How much revenue does Subcutaneous Drug Development & Delivery Consortium Inc generate?โ–ผ

Subcutaneous Drug Development & Delivery Consortium Inc reports $720K in annual revenue and holds $1.2M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Community Improvement & Capacity Building category, or browse all nonprofits in Oregon.

Subcutaneous Drug Development & Delivery Consortium Inc โ€” Beaverton, OR | GiveScope